{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:41:39Z","timestamp":1794814899589,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54- 762 CA260563-01"],"award-info":[{"award-number":["U54- 762 CA260563-01"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19-AI110483"],"award-info":[{"award-number":["U19-AI110483"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54- 762 CA260563-01"],"award-info":[{"award-number":["U54- 762 CA260563-01"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Department of Health & Human Services | U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["GCBER005"],"award-info":[{"award-number":["GCBER005"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Department of Health & Human Services | U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["GCBER008"],"award-info":[{"award-number":["GCBER008"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41590-024-02010-9","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T10:01:57Z","timestamp":1731405717000},"page":"131-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0487-1914","authenticated-orcid":false,"given":"Caterina E.","family":"Faliti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh T. P.","family":"Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabliha A.","family":"Anam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanaiah","family":"Cheedarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-3394","authenticated-orcid":false,"given":"M. Elliott","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeena Y.","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Kraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Runnstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Kyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midushi","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morrison-Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Quehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3094","authenticated-orcid":false,"given":"Natalie S.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneethamma","family":"Cheedarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Neish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-614X","authenticated-orcid":false,"given":"Rustom","family":"Antia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4940-5354","authenticated-orcid":false,"given":"John M.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-906X","authenticated-orcid":false,"given":"Eliver","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":false,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-8504","authenticated-orcid":false,"given":"Christopher D.","family":"Scharer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Khosroshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-5942","authenticated-orcid":false,"given":"F. Eun-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-587X","authenticated-orcid":false,"given":"Ignacio","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2010_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2010_CR2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2010_CR3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","volume":"385","author":"MG Thompson","year":"2021","unstructured":"Thompson, M. G. et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N. Engl. J. Med. 385, 1355\u20131371 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2010_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","volume":"604","author":"W Kim","year":"2022","unstructured":"Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\u2013145 (2022).","journal-title":"Nature"},{"key":"2010_CR5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025\u20131040 (2022).","journal-title":"Cell"},{"key":"2010_CR6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2021.12.026","volume":"185","author":"PA Mudd","year":"2022","unstructured":"Mudd, P. A. et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185, 603\u2013613 (2022).","journal-title":"Cell"},{"key":"2010_CR7","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434\u20132451 (2022).","journal-title":"Cell"},{"key":"2010_CR8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","volume":"185","author":"LB Rodda","year":"2022","unstructured":"Rodda, L. B. et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell 185, 1588\u20131601 (2022).","journal-title":"Cell"},{"key":"2010_CR9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","volume":"617","author":"WB Alsoussi","year":"2023","unstructured":"Alsoussi, W. B. et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Nature 617, 592\u2013598 (2023).","journal-title":"Nature"},{"key":"2010_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","volume":"607","author":"F Muecksch","year":"2022","unstructured":"Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature 607, 128\u2013134 (2022).","journal-title":"Nature"},{"key":"2010_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.13115","volume":"309","author":"DC Nguyen","year":"2022","unstructured":"Nguyen, D. C. et al. COVID-19 and plasma cells: is there long-lived protection? Immunol. Rev. 309, 40\u201363 (2022).","journal-title":"Immunol. Rev."},{"key":"2010_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310, 6\u201326 (2022).","journal-title":"Immunol. Rev."},{"key":"2010_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 385, 1761\u20131773 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2010_CR14","doi-asserted-by":"crossref","first-page":"e000479","DOI":"10.1136\/lupus-2021-000479","volume":"8","author":"W Tang","year":"2021","unstructured":"Tang, W., Askanase, A. D., Khalili, L. & Merrill, J. T. SARS-CoV-2 vaccines in patients with SLE. Lupus Sci. Med. 8, e000479 (2021).","journal-title":"Lupus Sci. Med."},{"key":"2010_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0000000000000525","volume":"30","author":"A Mathian","year":"2018","unstructured":"Mathian, A., Pha, M. & Amoura, Z. Lupus and vaccinations. Curr. Opin. Rheumatol. 30, 465\u2013470 (2018).","journal-title":"Curr. Opin. Rheumatol."},{"key":"2010_CR16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","volume":"80","author":"V Furer","year":"2021","unstructured":"Furer, V. et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann. Rheum. Dis. 80, 1330\u20131338 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"2010_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/annrheumdis-2021-221097","volume":"81","author":"Q Moyon","year":"2022","unstructured":"Moyon, Q. et al. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus. Ann. Rheum. Dis. 81, 575\u2013583 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"2010_CR18","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/rheumatology\/keac459","volume":"62","author":"SC Boedecker-Lips","year":"2023","unstructured":"Boedecker-Lips, S. C., Cla\u00dfen, P., Kraus, D. & Weinmann-Menke, J. Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus. Rheumatology (Oxford) 62, e34\u2013e35 (2023).","journal-title":"Rheumatology (Oxford)"},{"key":"2010_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","volume":"6","author":"I Sanz","year":"2010","unstructured":"Sanz, I. & Lee, F. E.-H. B cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6, 326\u2013337 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2010_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12836","volume":"292","author":"R Ahmed","year":"2019","unstructured":"Ahmed, R., Ford, M. L. & Sanz, I. Regulation of T and B cell responses to chronic antigenic stimulation during infection, autoimmunity and transplantation. Immunol. Rev. 292, 5\u20138 (2019).","journal-title":"Immunol. Rev."},{"key":"2010_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.20171976","volume":"216","author":"CE Faliti","year":"2019","unstructured":"Faliti, C. E. et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J. Exp. Med. 216, 317\u2013336 (2019).","journal-title":"J. Exp. Med."},{"key":"2010_CR22","doi-asserted-by":"crossref","first-page":"e127885","DOI":"10.1172\/jci.insight.127885","volume":"4","author":"J Suurmond","year":"2019","unstructured":"Suurmond, J. et al. Patterns of ANA+ B cells for SLE patient stratification. JCI Insight 4, e127885 (2019).","journal-title":"JCI Insight"},{"key":"2010_CR23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2021-220349","volume":"80","author":"SA Jenks","year":"2021","unstructured":"Jenks, S. A. et al. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus. Ann. Rheum. Dis. 80, 1190\u20131200 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"2010_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 (2018).","journal-title":"Immunity"},{"key":"2010_CR25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff, M. C. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\u20131516 (2020).","journal-title":"Nat. Immunol."},{"key":"2010_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrd3436","volume":"10","author":"I Sanz","year":"2011","unstructured":"Sanz, I., Yasothan, U. & Kirkpatrick, P. Belimumab. Nat. Rev. Drug Discov. 10, 335\u2013336 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2010_CR27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ebiom.2018.12.035","volume":"40","author":"D Ramsk\u00f6ld","year":"2019","unstructured":"Ramsk\u00f6ld, D. et al. B cell alterations during BAFF inhibition with belimumab in SLE. EBioMedicine 40, 517\u2013527 (2019).","journal-title":"EBioMedicine"},{"key":"2010_CR28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/immunohorizons.2100011","volume":"5","author":"NS Haddad","year":"2021","unstructured":"Haddad, N. S. et al. One-stop serum assay identifies COVID-19 disease severity and vaccination responses. Immunohorizons 5, 322\u2013335 (2021).","journal-title":"Immunohorizons"},{"key":"2010_CR29","doi-asserted-by":"crossref","first-page":"110368","DOI":"10.1016\/j.celrep.2022.110368","volume":"38","author":"G Beaudoin-Bussi\u00e8res","year":"2022","unstructured":"Beaudoin-Bussi\u00e8res, G. et al. A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. Cell Rep. 38, 110368 (2022).","journal-title":"Cell Rep."},{"key":"2010_CR30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042 (2020).","journal-title":"Cell"},{"key":"2010_CR31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","volume":"53","author":"H Liu","year":"2020","unstructured":"Liu, H. et al. Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity. Immunity 53, 1272\u20131280 (2020).","journal-title":"Immunity"},{"key":"2010_CR32","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41590-021-01051-8","volume":"22","author":"S Ravichandran","year":"2021","unstructured":"Ravichandran, S. et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nat. Immunol. 22, 1452\u20131464 (2021).","journal-title":"Nat. Immunol."},{"key":"2010_CR33","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1200\/JCO.21.02257","volume":"40","author":"AK Nooka","year":"2022","unstructured":"Nooka, A. K. et al. Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma. J. Clin. Oncol. 40, 3057\u20133064 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2010_CR34","doi-asserted-by":"crossref","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen, K. W. et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep. Med. 2, 100354 (2021).","journal-title":"Cell Rep. Med."},{"key":"2010_CR35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton, C. M. et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat. Immunol. 16, 755\u2013765 (2015).","journal-title":"Nat. Immunol."},{"key":"2010_CR36","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178, 6624\u20136633 (2007).","journal-title":"J. Immunol."},{"key":"2010_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-022-05273-0","volume":"611","author":"MC Woodruff","year":"2022","unstructured":"Woodruff, M. C. et al. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19. Nature 611, 139\u2013147 (2022).","journal-title":"Nature"},{"key":"2010_CR38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.31138\/mjr.32.3.192","volume":"32","author":"A Sachinidis","year":"2021","unstructured":"Sachinidis, A. & Garyfallos, A. Double negative (DN) B cells: a connecting bridge between rheumatic diseases and COVID-19? Mediterr. J. Rheumatol. 32, 192\u2013199 (2021).","journal-title":"Mediterr. J. Rheumatol."},{"key":"2010_CR39","doi-asserted-by":"crossref","first-page":"112630","DOI":"10.1016\/j.celrep.2023.112630","volume":"42","author":"H Allard-Chamard","year":"2023","unstructured":"Allard-Chamard, H. et al. Extrafollicular IgD\u2212CD27\u2212CXCR5\u2212CD11c\u2212 DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19. Cell Rep. 42, 112630 (2023).","journal-title":"Cell Rep."},{"key":"2010_CR40","doi-asserted-by":"crossref","first-page":"eaai8153","DOI":"10.1126\/sciimmunol.aai8153","volume":"2","author":"D Lau","year":"2017","unstructured":"Lau, D. et al. Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation. Sci. Immunol. 2, eaai8153 (2017).","journal-title":"Sci. Immunol."},{"key":"2010_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/vaccines6030050","volume":"6","author":"G Bowyer","year":"2018","unstructured":"Bowyer, G. et al. Activation-induced markers detect vaccine-specific CD4+ T cell responses not measured by assays conventionally used in clinical trials. Vaccines (Basel) 6, 50 (2018).","journal-title":"Vaccines (Basel)"},{"key":"2010_CR42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A. & Smith, K. G. C. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612\u2013616 (2015).","journal-title":"Nature"},{"key":"2010_CR43","doi-asserted-by":"crossref","first-page":"e130062","DOI":"10.1172\/jci.insight.130062","volume":"4","author":"AV Bocharnikov","year":"2019","unstructured":"Bocharnikov, A. V. et al. PD-1hiCXCR5\u2212 T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight 4, e130062 (2019).","journal-title":"JCI Insight"},{"key":"2010_CR44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41586-024-07627-2","volume":"631","author":"C Law","year":"2024","unstructured":"Law, C. et al. Interferon subverts an AHR\u2013JUN axis to promote CXCL13+ T cells in lupus. Nature 631, 857\u2013866 (2024).","journal-title":"Nature"},{"key":"2010_CR45","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.22.00088","volume":"40","author":"A Chang","year":"2022","unstructured":"Chang, A. et al. Humoral responses against SARS-CoV-2 and variants of concern after mRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia. J. Clin. Oncol. 40, 3020\u20133031 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2010_CR46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cell.2022.01.027","volume":"185","author":"K Lederer","year":"2022","unstructured":"Lederer, K. et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 185, 1008\u20131024 (2022).","journal-title":"Cell"},{"key":"2010_CR47","doi-asserted-by":"crossref","first-page":"e0263328","DOI":"10.1371\/journal.pone.0263328","volume":"17","author":"J Bassi","year":"2022","unstructured":"Bassi, J. et al. Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients. PLoS ONE 17, e0263328 (2022).","journal-title":"PLoS ONE"},{"key":"2010_CR48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ajt.16851","volume":"22","author":"M Kantauskaite","year":"2022","unstructured":"Kantauskaite, M. et al. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. Am. J. Transpl. 22, 634\u2013639 (2022).","journal-title":"Am. J. Transpl."},{"key":"2010_CR49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","volume":"37","author":"SK Lee","year":"2012","unstructured":"Lee, S. K. et al. Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37, 880\u2013892 (2012).","journal-title":"Immunity"},{"key":"2010_CR50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri2637","volume":"9","author":"CG Vinuesa","year":"2009","unstructured":"Vinuesa, C. G., Sanz, I. & Cook, M. C. Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 9, 845\u2013857 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"2010_CR51","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","volume":"53","author":"RA Elsner","year":"2020","unstructured":"Elsner, R. A. & Shlomchik, M. J. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136\u20131150 (2020).","journal-title":"Immunity"},{"key":"2010_CR52","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","volume":"20","author":"CD Scharer","year":"2019","unstructured":"Scharer, C. D. et al. Epigenetic programming underpins B cell dysfunction in human SLE. Nat. Immunol. 20, 1071\u20131082 (2019).","journal-title":"Nat. Immunol."},{"key":"2010_CR53","doi-asserted-by":"crossref","first-page":"e41641","DOI":"10.7554\/eLife.41641","volume":"8","author":"E Zumaquero","year":"2019","unstructured":"Zumaquero, E. et al. IFN\u03b3 induces epigenetic programming of human T-bethi B cells and promotes TLR7\/8 and IL-21 induced differentiation. eLife 8, e41641 (2019).","journal-title":"eLife"},{"key":"2010_CR54","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","volume":"27","author":"SA Apostolidis","year":"2021","unstructured":"Apostolidis, S. A. et al. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. Nat. Med. 27, 1990\u20132001 (2021).","journal-title":"Nat. Med."},{"key":"2010_CR55","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajt.2023.03.014","volume":"23","author":"WA Werbel","year":"2023","unstructured":"Werbel, W. A. et al. Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose. Am. J. Transplant. 23, 744\u2013758 (2023).","journal-title":"Am. J. Transplant."},{"key":"2010_CR56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.20130505","volume":"211","author":"R Goenka","year":"2014","unstructured":"Goenka, R. et al. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation. J. Exp. Med. 211, 45\u201356 (2014).","journal-title":"J. Exp. Med."},{"key":"2010_CR57","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.171.2.547","volume":"171","author":"KA Vora","year":"2003","unstructured":"Vora, K. A. et al. Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J. Immunol. 171, 547\u2013551 (2003).","journal-title":"J. Immunol."}],"updated-by":[{"DOI":"10.1038\/s41590-024-02045-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02010-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:14:54Z","timestamp":1735870494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02010-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2010"],"URL":"https:\/\/doi.org\/10.1038\/s41590-024-02010-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41590-024-02045-y","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-024-02045-y","URL":"https:\/\/doi.org\/10.1038\/s41590-024-02045-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.E.-H.L. is the founder of MicroB-plex, Inc., and has research grants with Genentech. I.S. has research grants with Glaxo Smith Kline. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}